Mallam E - Search Results

1

Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.

Mallam E, Kemp K, Wilkins A, Rice C, Scolding N. Mallam E, et al. Mult Scler. 2010 Aug;16(8):909-18. doi: 10.1177/1352458510371959. Epub 2010 Jun 11. Mult Scler. 2010. PMID: 20542920

2

Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis.

Rice CM, Mallam EA, Whone AL, Walsh P, Brooks DJ, Kane N, Butler SR, Marks DI, Scolding NJ. Rice CM, et al. Among authors: mallam ea. Clin Pharmacol Ther. 2010 Jun;87(6):679-85. doi: 10.1038/clpt.2010.44. Epub 2010 May 5. Clin Pharmacol Ther. 2010. PMID: 20445531 Clinical Trial.

3

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells.

Kemp K, Gordon D, Wraith DC, Mallam E, Hartfield E, Uney J, Wilkins A, Scolding N. Kemp K, et al. Among authors: mallam e. Neuropathol Appl Neurobiol. 2011 Feb;37(2):166-78. doi: 10.1111/j.1365-2990.2010.01122.x. Neuropathol Appl Neurobiol. 2011. PMID: 20819172 Free PMC article.

4

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Wilkins A, et al. Among authors: mallam e. Stem Cell Res. 2009 Jul;3(1):63-70. doi: 10.1016/j.scr.2009.02.006. Epub 2009 Mar 27. Stem Cell Res. 2009. PMID: 19411199 Free article.

5

Stem cells in genetic myelin disorders.

Kemp K, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Among authors: mallam e. Regen Med. 2010 May;5(3):425-39. doi: 10.2217/rme.10.10. Regen Med. 2010. PMID: 20455653 Review.

6

Changes in expression of the antioxidant enzyme SOD3 occur upon differentiation of human bone marrow-derived mesenchymal stem cells in vitro.

Nightingale H, Kemp K, Gray E, Hares K, Mallam E, Scolding N, Wilkins A. Nightingale H, et al. Among authors: mallam e. Stem Cells Dev. 2012 Jul 20;21(11):2026-35. doi: 10.1089/scd.2011.0516. Epub 2012 Jan 26. Stem Cells Dev. 2012. PMID: 22132904

7

The Diagnosis of MS.

Mallam E, Scolding N. Mallam E, et al. Int MS J. 2009 Apr;16(1):19-25. Int MS J. 2009. PMID: 19413922

8

Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival.

Kemp K, Hares K, Mallam E, Heesom KJ, Scolding N, Wilkins A. Kemp K, et al. Among authors: mallam e. J Neurochem. 2010 Sep;114(6):1569-80. doi: 10.1111/j.1471-4159.2009.06553.x. Epub 2010 Aug 19. J Neurochem. 2010. PMID: 20028455 Free article.

9

Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy.

Kemp K, Morse R, Wexler S, Cox C, Mallam E, Hows J, Donaldson C. Kemp K, et al. Among authors: mallam e. Ann Hematol. 2010 Jul;89(7):701-13. doi: 10.1007/s00277-009-0896-2. Epub 2010 Jan 30. Ann Hematol. 2010. PMID: 20119670 Clinical Trial.

10

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

Kemp K, Gray E, Mallam E, Scolding N, Wilkins A. Kemp K, et al. Among authors: mallam e. Stem Cell Rev Rep. 2010 Dec;6(4):548-59. doi: 10.1007/s12015-010-9178-6. Stem Cell Rev Rep. 2010. PMID: 20683679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters